1. TiedeA, BastischI, SchubertJ, OrleanP, SchmidtRE (1999) Biosynthesis of glycosylphosphatidylinositols in mammalian and unicellular microbes. Biol Chem 380: 503–523.
2. McConvilleMJ, MenonAK (2000) Recent developments in the cell biology and biochemistry of glycosylphosphatidylinositol lipids. Mol Membr Biol 17: 1–16.
3. FujitaM, KinoshitaT (2012) GPI-anchor remodeling: potential functions of GPI-anchors in intracellular trafficking and membrane dynamics. Biochim Biophys Acta 1821: 1050–1058.
4. TanakaS, MaedaY, TashimaY, KinoshitaT (2004) Inositol deacylation of glycosylphosphatidylinositol-anchored proteins is mediated by mammalian PGAP1 and yeast Bst1p. J Biol Chem 279: 14256–14263.
5. FujitaM, MaedaY, RaM, YamaguchiY, TaguchiR, et al. (2009) GPI glycan remodeling by PGAP5 regulates transport of GPI-anchored proteins from the ER to the Golgi. Cell 139: 352–365.
6. TashimaY, TaguchiR, MurataC, AshidaH, KinoshitaT, et al. (2006) PGAP2 is essential for correct processing and stable expression of GPI-anchored proteins. Mol Biol Cell 17: 1410–1420.
7. MaedaY, TashimaY, HoujouT, FujitaM, Yoko-oT, et al. (2007) Fatty acid remodeling of GPI-anchored proteins is required for their raft association. Mol Biol Cell 18: 1497–1506.
8. AlmeidaAM, MurakamiY, BakerA, MaedaY, RobertsIA, et al. (2007) Targeted therapy for inherited GPI deficiency. N Engl J Med 356: 1641–1647.
9. JohnstonJJ, GropmanAL, SappJC, TeerJK, MartinJM, et al. (2012) The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria. Am J Hum Genet 90: 295–300.
10. van der CrabbenSN, HarakalovaM, BrilstraEH, van BerkestijnFM, HofstedeFC, et al. (2013) Expanding the spectrum of phenotypes associated with germline PIGA mutations: A child with developmental delay, accelerated linear growth, facial dysmorphisms, elevated alkaline phosphatase, and progressive CNS abnormalities. Am J Med Genet A 164: 29–35.
11. SwobodaKJ, MargrafRL, CareyJC, ZhouH, NewcombTM, et al. (2013) A novel germline PIGA mutation in Ferro-Cerebro-Cutaneous syndrome: A neurodegenerative X-linked epileptic encephalopathy with systemic iron-overload. Am J Med Genet A 164: 17–28.
12. KrawitzPM, MurakamiY, HechtJ, KrugerU, HolderSE, et al. (2012) Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation. Am J Hum Genet 91: 146–151.
13. KrawitzPM, SchweigerMR, RodelspergerC, MarcelisC, KolschU, et al. (2010) Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome. Nat Genet 42: 827–829.
14. HornD, WieczorekD, MetcalfeK, BaricI, PalezacL, et al. (2013) Delineation of PIGV mutation spectrum and associated phenotypes in hyperphosphatasia with mental retardation syndrome. Eur J Hum Genet doi:10.1038/ejhg.2013.241
15. KukiI, TakahashiYukitoshi, OkazakiShin, KawawakiHisashi, EharaEiji, InoueNorimitsu, KinoshitaTaroh, MurakamiYoshiko (2013) Case report on vitamin B6 responsive epilepsy due to inherited GPI deficiency. Neurology 81: 1467–1469.
16. NakamuraK, OsakaH, MurakamiY, AnzaiR, NishiyamaK, et al. (2014) PIGO mutations in intractable epilepsy and severe developmental delay with mild elevation of alkaline phosphatase levels. Epilepsia 55(2): e13–e17.
17. MaydanG, NoymanI, Har-ZahavA, NeriahZB, Pasmanik-ChorM, et al. (2011) Multiple congenital anomalies-hypotonia-seizures syndrome is caused by a mutation in PIGN. J Med Genet 48: 383–389.
18. OhbaC, OkamotoN, MurakamiY, SuzukiY, TsurusakiY, et al. (2013) PIGN mutations cause congenital anomalies, developmental delay, hypotonia, epilepsy, and progressive cerebellar atrophy. Neurogenetics doi:10.1007/s10048-013-0384-7
19. NgBG, HackmannK, JonesMA, EroshkinAM, HeP, et al. (2012) Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome. Am J Hum Genet 90: 685–688.
20. KvarnungM, NilssonD, LindstrandA, KorenkeGC, ChiangSC, et al. (2013) A novel intellectual disability syndrome caused by GPI anchor deficiency due to homozygous mutations in PIGT. J Med Genet 50 521–528.
21. HansenL, TawamieH, MurakamiY, MangY, Ur RehmanS, et al. (2013) Hypomorphic Mutations in PGAP2, Encoding a GPI-Anchor-Remodeling Protein, Cause Autosomal-Recessive Intellectual Disability. Am J Hum Genet 92: 575–583.
22. KrawitzPM, MurakamiY, RiessA, HietalaM, KrugerU, et al. (2013) PGAP2 Mutations, Affecting the GPI-Anchor-Synthesis Pathway, Cause Hyperphosphatasia with Mental Retardation Syndrome. Am J Hum Genet 92: 584–589.
23. MurakamiY, KanzawaN, SaitoK, KrawitzPM, MundlosS, et al. (2012) Mechanism for release of alkaline phosphatase caused by glycosylphosphatidylinositol deficiency in patients with hyperphosphatasia mental retardation syndrome. J Biol Chem 287: 6318–6325.
24. Abou JamraR, WohlfartS, ZweierM, UebeS, PriebeL, et al. (2011) Homozygosity mapping in 64 Syrian consanguineous families with non-specific intellectual disability reveals 11 novel loci and high heterogeneity. Eur J Hum Genet 19: 1161–1166.
25. Abou JamraR, PhilippeO, Raas-RothschildA, EckSH, GrafE, et al. (2011) Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature. Am J Hum Genet 88: 788–795.
26. MontosiG, DonovanA, TotaroA, GarutiC, PignattiE, et al. (2001) Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108: 619–623.
27. NjajouOT, VaessenN, JoosseM, BerghuisB, van DongenJW, et al. (2001) A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 28: 213–214.
28. KurowskiMA, BujnickiJM (2003) GeneSilico protein structure prediction meta-server. Nucleic Acids Res 31: 3305–3307.
29. SanchezR, SaliA (2000) Comparative protein structure modeling. Introduction and practical examples with modeller. Methods Mol Biol 143: 97–129.
30. RauchA, WieczorekD, GrafE, WielandT, EndeleS, et al. (2012) Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 380: 1674–1682.
31. VolwerkJJ, ShashidharMS, KuppeA, GriffithOH (1990) Phosphatidylinositol-specific phospholipase C from Bacillus cereus combines intrinsic phosphotransferase and cyclic phosphodiesterase activities: a 31P NMR study. Biochemistry 29: 8056–8062.
32. UedaY, YamaguchiR, IkawaM, OkabeM, MoriiE, et al. (2007) PGAP1 knock-out mice show otocephaly and male infertility. J Biol Chem 282: 30373–30380.
33. ZoltewiczJS, PlummerNW, LinMI, PetersonAS (1999) oto is a homeotic locus with a role in anteroposterior development that is partially redundant with Lim1. Development 126: 5085–5095.
34. ZoltewiczJS, AshiqueAM, ChoeY, LeeG, TaylorS, et al. (2009) Wnt signaling is regulated by endoplasmic reticulum retention. PLoS One 4: e6191.
35. McKeanDM, NiswanderL (2012) Defects in GPI biosynthesis perturb Cripto signaling during forebrain development in two new mouse models of holoprosencephaly. Biol Open 1: 874–883.
36. SeelowD, SchuelkeM, HildebrandtF, NurnbergP (2009) HomozygosityMapper–an interactive approach to homozygosity mapping. Nucleic Acids Res 37: W593–599.
37. McKennaA, HannaM, BanksE, SivachenkoA, CibulskisK, et al. (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20: 1297–1303.
38. LiH, HandsakerB, WysokerA, FennellT, RuanJ, et al. (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078–2079.
39. WangK, LiM, HakonarsonH (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38: e164.
40. AbecasisGR, AltshulerD, AutonA, BrooksLD, DurbinRM, et al. (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061–1073.